• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本冠状动脉痉挛性心绞痛患者中Kir6.1的突变分析。

Mutational analysis of Kir6.1 in Japanese patients with coronary spastic angina.

作者信息

Tomita Hirofumi, Sasaki Satoko, Osanai Tomohiro, Nakano Takao, Higuma Takumi, Yokoyama Jin, Hanada Hiroyuki, Yasujima Minoru, Okumura Ken

机构信息

The Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki 036-8562, Japan.

出版信息

Int J Mol Med. 2006 Oct;18(4):589-91.

PMID:16964409
Abstract

The etiology of coronary spastic angina (CSA) remains uncertain. Mice lacking the gene encoding the inwardly rectifying K(+) channel Kir6.1 were developed as an animal model of CSA. We investigated whether mutation in the coding region of the Kir6.1 gene is detected in Japanese patients with CSA. The study population included 19 Japanese patients with CSA (10 men and 9 women with a mean age of 61+/-14 years). Mutational analysis of the coding region of Kir6.1 was performed by direct sequencing. We found no missense or nonsense mutations in these samples, but we found in one female CSA patient, a single base substitution (C to T) at nucleotide position 111 in exon 2 of the coding region, which was heterozygous and did not cause amino acid substitution (Ile37Ile, silent mutation). In the remaining 18 patients, no base substitution was detected in the coding region of the Kir6.1 gene. No mutation that alters primary structure of Kir6.1 was detected in Japanese patients with CSA. The results indicate that abnormality in the primary structure of Kir6.1 may not be involved in the genetic pathogenesis of CSA in humans.

摘要

冠状动脉痉挛性心绞痛(CSA)的病因仍不明确。缺乏编码内向整流钾通道Kir6.1基因的小鼠被培育为CSA的动物模型。我们调查了在日本CSA患者中是否能检测到Kir6.1基因编码区的突变。研究对象包括19名日本CSA患者(10名男性和9名女性,平均年龄61±14岁)。通过直接测序对Kir6.1编码区进行突变分析。我们在这些样本中未发现错义或无义突变,但在一名女性CSA患者中,编码区第2外显子核苷酸位置111处发现单个碱基替换(C到T),此为杂合突变且未导致氨基酸替换(Ile37Ile,沉默突变)。在其余18名患者中,未在Kir6.1基因编码区检测到碱基替换。在日本CSA患者中未检测到改变Kir6.1一级结构的突变。结果表明,Kir6.1一级结构异常可能与人类CSA的遗传发病机制无关。

相似文献

1
Mutational analysis of Kir6.1 in Japanese patients with coronary spastic angina.日本冠状动脉痉挛性心绞痛患者中Kir6.1的突变分析。
Int J Mol Med. 2006 Oct;18(4):589-91.
2
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion.意大利冠状动脉血管运动异常患者中未检测到Kir6.1/KCNJ8突变。
Int J Mol Med. 2003 Oct;12(4):509-12.
3
Identification of two novel frameshift mutations in the KCNJ11 gene in two Italian patients affected by Congenital Hyperinsulinism of Infancy.在两名患有婴儿期先天性高胰岛素血症的意大利患者中鉴定出KCNJ11基因的两个新的移码突变。
Exp Mol Pathol. 2007 Aug;83(1):59-64. doi: 10.1016/j.yexmp.2006.11.006. Epub 2007 Jan 17.
4
Alport syndrome. Molecular genetic aspects.奥尔波特综合征。分子遗传学方面。
Dan Med Bull. 2009 Aug;56(3):105-52.
5
Mutational analysis of the Kir6.1 gene in Chinese hypertensive patients treated with the novel ATP-sensitive potassium channel opener iptakalim.新型ATP敏感性钾通道开放剂伊伐卡林治疗的中国高血压患者Kir6.1基因的突变分析
Exp Ther Med. 2011 Jul;2(4):757-760. doi: 10.3892/etm.2011.259. Epub 2011 Apr 28.
6
Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.通过破坏内向整流钾离子通道蛋白6.1构建变异型心绞痛小鼠模型。
Nat Med. 2002 May;8(5):466-72. doi: 10.1038/nm0502-466.
7
Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome.患者安德森-塔威利综合征中 KCNJ2 基因的新的从头突变。
Pediatr Neurol. 2009 Dec;41(6):464-6. doi: 10.1016/j.pediatrneurol.2009.07.010.
8
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.一种导致DEND综合征的新型突变:一种可治疗的胰腺和脑部通道病。
Neurology. 2007 Sep 25;69(13):1342-9. doi: 10.1212/01.wnl.0000268488.51776.53. Epub 2007 Jul 25.
9
Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.幼儿糖尿病与低血糖以及钾通道Kir6.2亚基突变:治疗后果
Diabetes Metab. 2006 Dec;32(6):569-80. doi: 10.1016/S1262-3636(07)70311-7.
10
Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study.Kir6.2 E23K基因多态性对日本普通人群2型糖尿病发病的影响:久山研究
Diabetes. 2007 Nov;56(11):2829-33. doi: 10.2337/db06-1709.

引用本文的文献

1
Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review.冠状动脉痉挛相关心力衰竭综合征:文献综述。
Int J Mol Sci. 2023 Apr 19;24(8):7530. doi: 10.3390/ijms24087530.
2
Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm.增强的p122RhoGAP/DLC-1表达可能是冠状动脉痉挛的一个原因。
PLoS One. 2015 Dec 1;10(12):e0143884. doi: 10.1371/journal.pone.0143884. eCollection 2015.
3
Mutational analysis of the Kir6.1 gene in Chinese hypertensive patients treated with the novel ATP-sensitive potassium channel opener iptakalim.
新型ATP敏感性钾通道开放剂伊伐卡林治疗的中国高血压患者Kir6.1基因的突变分析
Exp Ther Med. 2011 Jul;2(4):757-760. doi: 10.3892/etm.2011.259. Epub 2011 Apr 28.
4
Muscle KATP channels: recent insights to energy sensing and myoprotection.肌 KATP 通道:能量感应和肌保护的新见解。
Physiol Rev. 2010 Jul;90(3):799-829. doi: 10.1152/physrev.00027.2009.